IL25 and asthma: Since ILC2s have been detected in airway tissues [20], thus we hypothesize that the augmented Th2-cytokines in nasal tissue from CRS patients with asthma may be derived from sinonasal tract ILC2s in response to enhanced IL-25, IL-33 and TSLP release.